3,983 Shares in CME Group Inc. $CME Bought by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC acquired a new stake in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 3,983 shares of the financial services provider’s stock, valued at approximately $1,043,000.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. bought a new position in shares of CME Group during the 2nd quarter worth approximately $6,749,965,000. Bank of America Corp DE boosted its stake in CME Group by 39.1% in the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock valued at $1,187,290,000 after buying an additional 1,130,587 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in CME Group in the 2nd quarter valued at $867,313,000. Alphabet Inc. bought a new stake in CME Group in the second quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in CME Group in the second quarter valued at $629,771,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CME has been the subject of several recent analyst reports. Barclays increased their price objective on CME Group from $270.00 to $281.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Piper Sandler lowered their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Finally, Morgan Stanley upped their target price on shares of CME Group from $330.00 to $337.00 and gave the stock an “overweight” rating in a report on Friday, October 9th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $292.94.

CME Group Stock Performance

NASDAQ:CME opened at $289.46 on Friday. The stock has a market capitalization of $104.08 billion, a P/E ratio of 24.55, a price-to-earnings-growth ratio of 3.74 and a beta of 0.24. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The firm has a 50 day moving average of $273.52 and a 200-day moving average of $270.60.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%. CME Group’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the prior year, the company earned $2.96 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.29 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were given a $1.30 dividend. The ex-dividend date was Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is presently 44.11%.

Insider Buying and Selling at CME Group

In other news, Director Elizabeth A. Cook sold 500 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the sale, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director William R. Shepard bought 293 shares of the stock in a transaction dated Friday, September 25th. The stock was acquired at an average price of $268.76 per share, with a total value of $78,746.68. Following the completion of the purchase, the director owned 263,289 shares of the company’s stock, valued at $70,761,551.64. This represents a 0.11% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.